Literature DB >> 20702149

Determination of the gamma-secretase inhibitor MK-0752 in human plasma by online extraction and electrospray tandem mass spectrometry (HTLC-ESI-MS/MS).

Feng Bai1, Michael Tagen, Courtney Colotta, Laura Miller, Maryam Fouladi, Clinton F Stewart.   

Abstract

A sensitive and rapid HTLC-ESI-MS/MS method with an advanced online sample preparation was developed for determination of the gamma-secretase inhibitor MK-0752 in human plasma using an internal standard. Plasma samples (100 microL) were diluted and injected directly onto an online extraction column (Cohesive Cyclone MAX 0.5 mm x 50 mm, > 30 microm), the sample matrix was washed out with an aqueous solution, and retained analytes were eluted out and transferred directly to the analytical column (Phenomenex Gemini 3 micron C18 110A, 50 mm x 2.0 mm at 50 degrees C) for separation using a gradient mobile phase. The eluted analytes were then detected on an API-3000 LC-MS/MS System with ESI and a negative multiple reaction monitoring mode. The monitored ion transitions were m/z 441-->175 for MK-0752 and 496-->175 for the internal standard. Online extraction recoveries were 81%. The method was validated and was linear in the range of 0.05-50 microg/mL. Within-day and between-day precisions were<8.6%, and accuracies were 0.7 and 7.1%. This method was applied to the measurement of plasma MK-0752 levels in a Phase I study of pediatric patients with recurrent or refractory brain tumors. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20702149      PMCID: PMC2926936          DOI: 10.1016/j.jchromb.2010.07.019

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  11 in total

Review 1.  Ion suppression in mass spectrometry.

Authors:  Thomas M Annesley
Journal:  Clin Chem       Date:  2003-07       Impact factor: 8.327

2.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

3.  Simultaneous determination of cyclophosphamide and carboxyethylphosphoramide mustard in human plasma using online extraction and electrospray tandem mass spectrometry (HTLC-ESI-MS/MS).

Authors:  Feng Bai; Charles H Fraga; Michael Tagen; Paula Schaiquevich; Nikolaus Hagedorn; Clinton F Stewart
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-04-24       Impact factor: 3.205

Review 4.  Notch signaling in leukemia.

Authors:  Jon C Aster; Warren S Pear; Stephen C Blacklow
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

Review 5.  Notch signaling in pediatric malignancies.

Authors:  Patrick A Zweidler-McKay
Journal:  Curr Oncol Rep       Date:  2008-11       Impact factor: 5.075

Review 6.  Pediatric developmental therapies: interesting new drugs now in early-stage clinical trials.

Authors:  Margaret E Macy; Kelly K Sawczyn; Timothy P Garrington; Douglas K Graham; Lia Gore
Journal:  Curr Oncol Rep       Date:  2008-11       Impact factor: 5.075

Review 7.  Therapeutic potential of gamma-secretase inhibitors and modulators.

Authors:  Bruno P Imbimbo
Journal:  Curr Top Med Chem       Date:  2008       Impact factor: 3.295

8.  Determination of Cloretazine (VNP40101M) and its active metabolite (VNP4090CE) in human plasma by liquid chromatography electrospray tandem mass spectrometry (LC-ESI-MS/MS).

Authors:  Feng Bai; Patton Minkin; Charles H Fraga; Melinda A O'Shaughnessy; Sri Gururangan; Clinton F Stewart
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-03-24       Impact factor: 3.205

Review 9.  Tumour-initiating cells: challenges and opportunities for anticancer drug discovery.

Authors:  Bin-Bing S Zhou; Haiying Zhang; Marc Damelin; Kenneth G Geles; Justin C Grindley; Peter B Dirks
Journal:  Nat Rev Drug Discov       Date:  2009-10       Impact factor: 84.694

10.  Determination of a novel gamma-secretase inhibitor in human plasma and cerebrospinal fluid using automated 96 well solid phase extraction and liquid chromatography/tandem mass spectrometry.

Authors:  Catherine Z Matthews; Eric J Woolf
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-01-06       Impact factor: 3.205

View more
  2 in total

1.  Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study.

Authors:  Lindsey M Hoffman; Maryam Fouladi; James Olson; Vinay M Daryani; Clinton F Stewart; Cynthia Wetmore; Mehmet Kocak; Arzu Onar-Thomas; Lars Wagner; Sridharan Gururangan; Roger J Packer; Susan M Blaney; Amar Gajjar; Larry E Kun; James M Boyett; Richard J Gilbertson
Journal:  Childs Nerv Syst       Date:  2015-05-01       Impact factor: 1.475

2.  Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study.

Authors:  Maryam Fouladi; Clinton F Stewart; James Olson; Lars M Wagner; Arzu Onar-Thomas; Mehmet Kocak; Roger J Packer; Stewart Goldman; Sridharan Gururangan; Amar Gajjar; Tim Demuth; Larry E Kun; James M Boyett; Richard J Gilbertson
Journal:  J Clin Oncol       Date:  2011-08-08       Impact factor: 44.544

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.